Login to Your Account

With Xolair Approved, Trio Sorts Options For Peanut Allergy Drug

By Randall Osborne

Monday, July 7, 2003
Last month, when the FDA approved Xolair for asthma, there was much rejoicing by Genentech Inc., Tanox Inc. and Novartis Pharma AG, which developed the monoclonal antibody in a three-way deal.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription